Alexandra Mancini
2020
In 2020, Alexandra Mancini earned a total compensation of $308.2K as Senior VP, Clinical & Regulatory Affairs at InMed Pharmaceuticals.
Compensation breakdown
Bonus | $78,058 |
---|---|
Salary | $230,133 |
Total | $308,191 |
Mancini received $230.1K in salary, accounting for 75% of the total pay in 2020.
Mancini also received $78.1K in bonus.
Rankings
In 2020, Alexandra Mancini's compensation ranked 12,079th out of 13,090 executives tracked by ExecPay. In other words, Mancini earned more than 7.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 12,079 out of 13,090 | 8th |
Division Manufacturing | 5,167 out of 5,624 | 8th |
Major group Chemicals And Allied Products | 2,102 out of 2,257 | 7th |
Industry group Drugs | 1,831 out of 1,957 | 6th |
Industry Pharmaceutical Preparations | 1,360 out of 1,462 | 7th |
Source: SEC filing on October 28, 2021.
Mancini's colleagues
We found two more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2020.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021